| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neogenomics Inc (NEO) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. NEO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.4K | $1.58M | - | |
| COO | 143.8K | $1.29M | - | |
| Dir | 131.0K | $1.17M | - | |
| VP | 75.3K | $674.9K | - | |
| Dir | 44.0K | $394.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | Gunn Neil | Director | Buy | 4,510 | $7.75 | $34,977.45 | +39.8% | -27.7% | +13.0% | |
| May 2, 2025 | Sherman Jeffrey Scott | Chief Financial Officer | Buy | 20,000 | $7.51 | $150,104.00 | +14.4% | -37.1% | +22.6% | |
| Nov 15, 2024 | Olivo Alicia C69 | General Counsel | Sell | 5,175 | $15.36 | $79,475.06 | -12.2% | -7.5% | -31.2% | |
| Aug 15, 2024 | Olivo Alicia C69 | General Counsel | Sell | 1,040 | $16.05 | $16,695.43 | -2.3% | +1.9% | -61.5% | |
| May 15, 2024 | Olivo Alicia C69 | General Counsel | Sell | 1,049 | $15.74 | $16,511.26 | -2.3% | +8.9% | -48.2% | |
| Mar 4, 2024 | Tetrault Lynn A. | Director | Sell | 6,112 | $15.97 | $97,578.69 | -10.9% | -15.9% | -41.9% | |
| Feb 15, 2024 | Olivo Alicia C69 | General Counsel | Sell | 2,587 | $14.96 | $38,712.90 | -6.9% | +1.5% | -3.2% | |
| Nov 17, 2023 | Olivo Alicia C69 | General Counsel | Sell | 2,669 | $18.39 | $49,082.91 | -6.7% | -23.2% | -22.5% | |
| Mar 7, 2022 | Bonello William | Chief Financial Officer | Sale+OE | 3,209 | $18.29 | $58,692.61 | -3.2% | -55.7% | +0.6% | |
| Dec 21, 2021 | McKenzie Kathryn B | Chief Financial Officer | Sale+OE | 1,846 | $35.00 | $64,610.00 | -13.6% | -50.7% | -72.2% |